Shilpa Medicare Ltd. NSE: SHILPAMED | BSE: 530549

Mid-range Performer

Download real time

813.90 -10.95 (-1.33%)

46.65% Gain from 52W Low

107.6K

NSE+BSE Volume

NSE 24 Sep, 2025 3:30 PM (IST)

Drug Approval

Shilpa Medicare gets EMA nod for Rivaroxaban, targeting the European market valued at $2.5 billion See details

Shilpa Medicare Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Shilpa Medicare Ltd. from all sources in a single place.

Load latest

Is Shilpa Medicare Ltd. worth buying?

248 Votes:

Buy 79.03%

Sell 11.69%

Hold 9.27%